NINDS Neuroscience Funding Announcements

Skip secondary menu

New Information from NINDS Application processes at NIH are changing. Applicant organizations are encouraged to start preparing for this transtion by registering with Grants.gov and NIH eRA Commons now.



Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Centers (U54)
Release Date: August 8, 2007
Announcement Number: RFA-NS-08-002
Application Receipt Date:
November 19, 2007   
Letter of Intent Date: October 22, 2007

Funding Contact: John PorterPh.D.
Program Area: Neurogenetics

Brief Description:
This funding opportunity announcement (FOA) solicits new (type 1) and competitive renewal (type 2) applications for the support of Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Centers. Successful applicants will join a network of existing Centers to foster the translation of new scientific findings and technological developments into novel treatments for the muscular dystrophies. Each Center may contain a mixture of basic, translational, or clinical research, as long as efforts are directed toward the steps required for therapeutic development, including therapeutic target identification, characterization, and validation, development of diagnostics and biomarkers to characterize or stratify patient populations, in vitro assay development, animal model development and characterization, candidate therapeutic efficacy screening, preclinical therapeutic optimization and FDA-required activities leading to an investigational new drug (IND) application, clinical infrastructure and studies in support of a clinical trial, patient-oriented natural history studies, and early stage clinical trials for one or more types of muscular dystrophy.

Choose an option to view additional funding announcements
New Announcements | Research Area | RFAs Only | PAs Only | RFPs Only | Notices Only | Supplements Only | All Announcements | Archives